BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29945782)

  • 21. Opportunistic salpingectomy for prevention of sporadic ovarian cancer - a jump from basic science to clinical practice?
    Ziętek A; Bogusiewicz M; Szumiło J; Rechberger T
    Ginekol Pol; 2016; 87(6):467-72. PubMed ID: 27418226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opportunistic Salpingectomy at the Time of Urogynecologic Surgery: Why, in Whom, and How?
    Catanzarite T; Eskander RN
    Female Pelvic Med Reconstr Surg; 2020 Jun; 26(6):401-406. PubMed ID: 31135579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Updates on Salpingectomy for the Prevention of Ovarian Cancer and Its Practice Patterns Worldwide.
    Dhakal S; Zheng YX; Yi XF
    Chin Med Sci J; 2017 Sep; 32(3):185-192. PubMed ID: 28956746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salpingectomy and Ovarian Cancer Prevention.
    Harris AL
    Nurs Womens Health; 2015 Dec-2016 Jan; 19(6):543-9. PubMed ID: 26682662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey.
    Steenbeek MP; van Lieshout LAM; Aarts JWM; Piek JMJ; Coppus SFPJ; Massuger LFAG; Hermens RPMG; de Hullu JA
    J Gynecol Oncol; 2019 Jan; 30(1):e2. PubMed ID: 30479086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic salpingectomy for prevention of ovarian cancer at the time of elective laparoscopic cholecystectomy.
    Tomasch G; Lemmerer M; Oswald S; Uranitsch S; Schauer C; Schütz AM; Bliem B; Berger A; Lang PFJ; Rosanelli G; Ronaghi F; Tschmelitsch J; Lax SF; Uranues S; Tamussino K
    Br J Surg; 2020 Apr; 107(5):519-524. PubMed ID: 32129898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contraception options for patients with known hereditary risk for ovarian cancer.
    Joy KM
    JAAPA; 2019 Nov; 32(11):37-41. PubMed ID: 31663894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale for opportunistic salpingectomy during gynecological surgery for a benign condition: A review of the available literature.
    Buffeteau A; Tanguy Le Gac Y; Weyl A; Chantalat E; Guerby P; Vidal F
    J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101829. PubMed ID: 32534217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Fallopian Tubes in the Development of Ovarian Cancer.
    Corzo C; Iniesta MD; Patrono MG; Lu KH; Ramirez PT
    J Minim Invasive Gynecol; 2017 Feb; 24(2):230-234. PubMed ID: 28007588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3 to 5 Years Later: Long-term Effects of Prophylactic Bilateral Salpingectomy on Ovarian Function.
    Venturella R; Lico D; Borelli M; Imbrogno MG; Cevenini G; Zupi E; Zullo F; Morelli M
    J Minim Invasive Gynecol; 2017 Jan; 24(1):145-150. PubMed ID: 27621194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of prophylactic salpingectomy during vaginal hysterectomy.
    Antosh DD; High R; Brown HW; Oliphant SS; Abed H; Philip N; Grimes CL
    Am J Obstet Gynecol; 2017 Nov; 217(5):605.e1-605.e5. PubMed ID: 28734829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does ovarian cancer start in the fallopian tubes? Possible implications for preventive adnexal removal].
    Steenbeek MP; Bulten J; Hoogerbrugge N; Massuger LFAG; Pijnenborg JMA; de Hullu JA
    Ned Tijdschr Geneeskd; 2018; 162():D2337. PubMed ID: 29676714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: A survey of current Australian practice.
    Kapurubandara S; Qin V; Gurram D; Anpalagan A; Merkur H; Hogg R; Brand A
    Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):606-11. PubMed ID: 26768958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States.
    Karia PS; Joshu CE; Visvanathan K
    Cancer Prev Res (Phila); 2021 Dec; 14(12):1101-1110. PubMed ID: 34413116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.
    Karnezis AN; Cho KR
    Clin Obstet Gynecol; 2017 Dec; 60(4):789-800. PubMed ID: 28719396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: What do national societies advise?
    Ntoumanoglou-Schuiki A; Tomasch G; Laky R; Taumberger N; Bjelic-Radisic V; Tamussino K
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():110-112. PubMed ID: 29704813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Evolution of and Evidence for Opportunistic Salpingectomy.
    Dilley SE; Straughn JM; Leath CA
    Obstet Gynecol; 2017 Oct; 130(4):814-824. PubMed ID: 28885426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Exclusive salpingectomy or prophylactic salpingo-oophorectomy? Critical analysis of the latest French guidelines].
    Chene G; Lamblin G
    Gynecol Obstet Fertil Senol; 2018 Jan; 46(1):1-3. PubMed ID: 29203396
    [No Abstract]   [Full Text] [Related]  

  • 39. Ovarian cancer risk reduction through opportunistic salpingectomy.
    Kwon JS
    J Gynecol Oncol; 2015 Apr; 26(2):83-6. PubMed ID: 25872888
    [No Abstract]   [Full Text] [Related]  

  • 40. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.